Feature Channels: Respiratory Diseases and Disorders

• share
• favorite_border

UAB’s Jessica Grayson, M.D., clears the confusion on how to tell COVID-19 from other respiratory illnesses.

• share
• favorite_border

The U.S. Centers for Disease Control and Prevention has awarded $15.88 million to the Wayne State University School of Medicine’s Department of Emergency Medicine to be the epicenter of a national study on viral infections that present in emergency departments across the county.

• share
• favorite_border

NCCN announces the publication of new NCCN Guidelines for Patients®: Small Cell Lung Cancer (SCLC), which is a neuroendocrine tumor type of lung cancer that is linked to smoking and tends to be aggressive. This guide is free to view or download at NCCN.org/patientguidelines and is funded by NCCN Foundation®.

• share
• favorite_border

The life-support system called ECMO can rescue COVID-19 patients from the brink of death, but not at the rates seen early in the pandemic, a new international study finds. Where once about 60% of such patients survived at least 90 days in spring 2020, by the end of the year it was just under half.

• share
• favorite_border

Today, on World Lung Day (WLD), members of the Forum of International Respiratory Societies (FIRS) and WLD partner organizations, such as the American Thoracic Society, are calling for respiratory health to be a top priority in global decision-making beyond the COVID-19 pandemic.

• share
• favorite_border

Respiratory syncytial virus, commonly called RSV, usually affects very young children in the winter months. But this year, physicians are treating an unusual, out-of-season surge both in California and across the country.

• share
• favorite_border

This discovery, published in the Proceedings of the National Academy of Sciences (PNAS), suggest that MUC5AC could become a target of better therapeutics to untangle the super thick and sticky mucus that plays a role in health problems for millions of people suffering from pulmonary conditions.

• share
• favorite_border

• share
• favorite_border

The Society of Thoracic Surgeons is highlighting two particularly interesting stories from COVID survivors who were on ECMO for months, with one patient eventually underdoing a double lung transplantation.

• share
• favorite_border

New data published in the New England Journal of Medicine (NEJM) and featured at the European Society for Medical Oncology (ESMO) Congress 2021 highlights a promising new treatment for individuals with HER2-mutant non-small cell lung cancer (NSCLC).

• share
• favorite_border

New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer.

• share
• favorite_border

A new study published online in the Annals of the American Thoracic Society provides the most exhaustive look to date at the risk factors, prevalence and population attributable risk (PAR) of developing chronic obstructive pulmonary disease (COPD) in U.S. Hispanics/Latinos under age 50. PAR estimates the proportion of disease attributable to exposure to disease-causing agents, such as smoking. The researchers used PAR to calculate the burden of early COPD that would be eliminated if the exposure did not take place.

• share
• favorite_border

Addenbrooke’s Hospital in Cambridge along with 20 other hospitals from across the world and healthcare technology leader, NVIDIA, have used artificial intelligence (AI) to predict Covid patients’ oxygen needs on a global scale.

• share
• favorite_border

For My Lung Health, the joint American Thoracic Society and American College of Chest Physicians (CHEST) campaign, is the winner of this year’s Pharmaceutical Executive APEX Awards in the respiratory category. The campaign, made possible by an educational grant from GlaxoSmithKline with additional support from Boehringer Ingelheim Pharmaceuticals, Inc., was launched in response to COVID-19.

• share
• favorite_border

La enfermedad pulmonar obstructiva crónica (EPOC) es la tercera causa principal de muerte en todo el mundo. El Dr. John Costello, especialista en medicina pulmonar de Mayo Clinic Healthcare en Londres, ofrece sugerencias respecto a cómo ayudar a respirar más fácilmente a quienes padecen EPOC.

• share
• favorite_border

据世界卫生组织（World Health Organization）统计，慢性阻塞性肺病(COPD)是全球第三大致死原因。COPD是一种慢性炎症性肺部疾病，可导致肺部气流受阻。伦敦Mayo Clinic Healthcare（妙佑医疗国际医疗保健）的肺内科医师John Costello（医学博士）为COPD患者提供了如何更轻松地呼吸的几点建议。

• share
• favorite_border

A doença pulmonar obstrutiva crônica (DPOC) é a terceira maior causa global de mortes, de acordo com a Organização Mundial da Saúde. John Costello, especialista em medicina pulmonar da Mayo Clinic Healthcare, em Londres, oferece dicas sobre como os pacientes de Covid podem respirar com mais conforto.

• share
• favorite_border

Lung surgery patients who utilize a comprehensive, evidence-based enhanced recovery after surgery (ERAS) program require fewer opioid prescriptions when discharged and this effect was sustained over the 4-year study period.

• share
• favorite_border

Losing weight and treating excess levels of fat in the blood may help prevent lung disease in firefighters exposed to dangerous levels of fine particles from fire, smoke, and toxic chemicals on Sept. 11, 2001, a new study shows.

• share
• favorite_border

• share
• favorite_border

The nationwide pulmonary fibrosis (PF) community will take a collective step forward to advance research, advocacy, and awareness in the Pulmonary Fibrosis Foundation's (PFF) National Walk Day on Saturday, Sept. 25, during Pulmonary Fibrosis Awareness Month.

• share
• favorite_border

Opening a new chapter in a long, storied history dating back to 1905, the American Thoracic Society is pleased to announce that it has completed a major rebrand which includes a new, elevated logo design and a refreshed mission statement asserting the Society’s leadership role in driving innovation in the respiratory space.

• share
• favorite_border

A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.5 million grant from the National Cancer Institute to develop a novel therapy to treat lung cancer.

• share
• favorite_border

A buildup of coronavirus in the lungs is likely behind the steep mortality rates seen in the pandemic, a new study finds. The results contrast with previous suspicions that simultaneous infections, such as bacterial pneumonia or overreaction of the body’s immune defense system, played major roles in heightened risk of death, the investigators say.

• share
• favorite_border

Drawing on SLAC facilities, Australian researchers have revealed how Streptococcus pneumoniae bacteria obtain manganese from our bodies, which could lead to better therapies to target the pathogen.